论文信息 - FLT3 kinase inhibitor TTT-3002 overcomes both activating and drug resistance mutations in FLT3 in acute myeloid leukemia. - 字舞流文

FLT3 kinase inhibitor TTT-3002 overcomes both activating and drug resistance mutations in FLT3 in acute myeloid leukemia.

M. Levis | D. Small | D. Leahy | A. Duffield | P. Brown | Li Li | B. Nguyen | Hayley S Ma | Allen B. Williams | A. Galanis